Revolution Medicines Inc (RVMD)

03:39 AM

What drives Revolution Medicines Inc. stock priceExplosive returns - Autocar Professional

03:39 AM

02:37 AM

What analysts say about Revolution Medicines Inc. Equity Warrant stockFree AI-Backed Trading Signals - Autocar Professional

02:37 AM

01:00 AM

Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib - GlobeNewswire

01:00 AM

12:12 PM

Is Revolution Medicines Inc. a good long term investmentSuperior trading gains - Autocar Professional

12:12 PM

09:18 AM

Castle Biosciences, Revolution Medicines get FDA breakthrough statuses - Seeking Alpha

09:18 AM

08:16 AM

FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug - Investing.com Canada

08:16 AM

02:20 AM

How will RVMD's EPS trend in Q1 2025? - AInvest

02:20 AM

Jul 22, 2025

What analysts say about Revolution Medicines Inc. stockFree Bull & Bear Market Updates - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Revolution Medicines Inc. Equity Warrant Stock Analysis and ForecastOutperformance with explosive growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Revolution Medicines Inc. Equity Warrant stock pricePhenomenal trading returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Revolution Medicines Inc. Stock Analysis and ForecastRapidly growing investment returns - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Is Revolution Medicines Inc. Equity Warrant a good long term investmentSky-high profits - Autocar Professional

Jul 20, 2025

Jul 18, 2025

(RVMD) On The My Stocks Page - news.stocktradersdaily.com

Jul 18, 2025

Jul 16, 2025

Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs - MSN

Jul 16, 2025

Jul 15, 2025

What makes Revolution Medicines Inc. Equity Warrant stock price move sharplyInvestor Friendly Risk Reward - beatles.ru

Jul 15, 2025

Jul 15, 2025

Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors - MSN

Jul 15, 2025

Jul 13, 2025

Revolution Medicines’ Daraxonrasib Granted FDA Breakthrough Therapy Designation for Pancreatic Cancer with KRAS G12 Mutations - MSN

Jul 13, 2025

Jul 10, 2025

Revolution Meds partners with AI specialist Iambic - The Pharma Letter

Jul 10, 2025

Jul 10, 2025

Revolution Medicines partners with Iambic for AI-driven drug discovery By Investing.com - Investing.com South Africa

Jul 10, 2025

Jul 09, 2025

Revolution Medicines, Inc. and Iambic Therapeutics Announce Technology and Research Collaboration Using Iambic's Ai Discovery Tools to Pursue New Drug Candidates - MarketScreener

Jul 09, 2025

Jul 09, 2025

Revolution Medicines, Iambic Therapeutics Form AI-Powered Drug Discovery Partnership - MarketScreener

Jul 09, 2025